Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Gabapentin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.1% during the forecast period.
This report presents the market size and development trends by detailing the Gabapentin market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gabapentin market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gabapentin industry and will help you to build a panoramic view of the industrial development.
Gabapentin Market, By Type:
Capsule
Tablet
Gabapentin Market, By Application:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Some of the leading players are as follows:
Intas
Alkem
Depomed
Glenmark
Marksans Pharma
Apotex
Mylan
Arbor Pharma
Jiangsu Hengrui
Novartis
Amneal
TEVA
Sailike
Pfizer
Aurobindo Pharma
Jiangsu Enhua
Sun Pharmaceutical
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Gabapentin Market: Technology Type Analysis
-
4.1 Gabapentin Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Gabapentin Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Capsule
4.3.2 Tablet
5 Gabapentin Market: Product Analysis
-
5.1 Gabapentin Product Market Share Analysis, 2018 & 2026
-
5.2 Gabapentin Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Gabapentin Market: Application Analysis
-
6.1 Gabapentin Application Market Share Analysis, 2018 & 2026
-
6.2 Gabapentin Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Epilepsy
6.3.2 Neuropathic Pain
6.3.3 Restless Legs Syndrome
6.3.4 Others
7 Gabapentin Market: Regional Analysis
-
7.1 Gabapentin Regional Market Share Analysis, 2018 & 2026
-
7.2 Gabapentin Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Intas
9.1.1 Intas Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Alkem
9.2.1 Alkem Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Depomed
9.3.1 Depomed Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Glenmark
9.4.1 Glenmark Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Marksans Pharma
9.5.1 Marksans Pharma Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Apotex
9.6.1 Apotex Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Mylan
9.7.1 Mylan Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Arbor Pharma
9.8.1 Arbor Pharma Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Jiangsu Hengrui
9.9.1 Jiangsu Hengrui Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Novartis
9.10.1 Novartis Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Amneal
9.11.1 Amneal Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 TEVA
9.12.1 TEVA Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Sailike
9.13.1 Sailike Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Pfizer
9.14.1 Pfizer Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Aurobindo Pharma
9.15.1 Aurobindo Pharma Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Jiangsu Enhua
9.16.1 Jiangsu Enhua Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Sun Pharmaceutical
9.17.1 Sun Pharmaceutical Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
The List of Tables and Figures (Totals 62 Figures and 148 Tables)
Figure Capsule Gabapentin market, 2015 - 2026 (USD Million)
Figure Tablet Gabapentin market, 2015 - 2026 (USD Million)
Figure Epilepsy market, 2015 - 2026 (USD Million)
Figure Neuropathic Pain market, 2015 - 2026 (USD Million)
Figure Restless Legs Syndrome market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Gabapentin market, by country, 2015 - 2026 (USD Million)
-
Table North America Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table North America Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table North America Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Canada Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Canada Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Europe Gabapentin market, by country, 2015 - 2026 (USD Million)
-
Table Europe Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Europe Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Europe Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Germany Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Germany Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table France Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table France Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Italy Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Italy Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Spain Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Spain Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gabapentin market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table China Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table China Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Japan Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Japan Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table India Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table India Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Gabapentin market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table MEA Gabapentin market, by country, 2015 - 2026 (USD Million)
-
Table MEA Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table MEA Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table MEA Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Gabapentin market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Gabapentin market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Gabapentin market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Intas Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alkem Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Depomed Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glenmark Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Marksans Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Apotex Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Arbor Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jiangsu Hengrui Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amneal Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table TEVA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sailike Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jiangsu Enhua Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
